BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+46.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
+$7.07B
(+37%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
231
New
17
Increased
84
Reduced
52
Closed
23
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$38.5M |
| 2 |
Generation Bio
GBIO
|
$30.2M |
| 3 |
Stryker
SYK
|
$27.2M |
| 4 |
Insulet
PODD
|
$25.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$23.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.3M |
| 2 |
Moderna
MRNA
|
$38.9M |
| 3 |
Illumina
ILMN
|
$38.1M |
| 4 |
Intuitive Surgical
ISRG
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$31.2M |
Sector Composition
| 1 | Healthcare | 96.05% |
| 2 | Industrials | 0.58% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.29% |
| 5 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
76
DELISTED
GenMark Diagnostics, Inc
GNMK
| $21.9M | 0.31% |
1,489,284
-922,642
| -38% | -$13.6M |
|
77
Inspire Medical Systems
INSP
$2.77B
| $21.3M | 0.3% |
244,250
+107,025
| +78% | +$9.31M |
|
78
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $20.7M | 0.29% |
1,157,400
+1,108,900
| +2,286% | +$19.8M |
|
|
AKCA
79
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $20M | 0.28% |
1,462,296
-1,741,948
| -54% | -$23.9M |
|
|
SWAV
80
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $19.8M | 0.28% |
418,089
+93,428
| +29% | +$4.43M |
|
|
LVGO
81
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $19.3M | 0.27% |
257,258
-13,974
| -5% | -$1.05M |
|
82
Glaukos
GKOS
$5.5B
| $19M | 0.27% |
493,811
+81,188
| +20% | +$3.12M |
|
|
AXNX
83
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18.1M | 0.26% |
516,428
+337,095
| +188% | +$11.8M |
|
84
Penumbra
PEN
$10.6B
| $17.6M | 0.25% |
98,152
+16,013
| +19% | +$2.86M |
|
|
GTHX
85
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $17.5M | 0.25% |
721,925
| – | – |
|
86
Globus Medical
GMED
$8.27B
| $16.6M | 0.23% |
347,729
+9,662
| +3% | +$461K |
|
|
CHNG
87
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $16.3M | 0.23% |
1,455,240
+377,665
| +35% | +$4.23M |
|
|
ONEM
88
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $16.2M | 0.23% |
446,807
+196,807
| +79% | +$7.15M |
|
89
CVS Health
CVS
$92.8B
| $15.1M | 0.21% |
231,681
+18,700
| +9% | +$1.21M |
|
90
NeoGenomics
NEO
$1.13B
| $15M | 0.21% |
+485,470
| New | +$15M |
|
91
ResMed
RMD
$40.2B
| $14.9M | 0.21% |
77,805
-700
| -0.9% | -$134K |
|
92
Veeva Systems
VEEV
$44B
| $14.8M | 0.21% |
63,056
+12,172
| +24% | +$2.85M |
|
93
Regeneron Pharmaceuticals
REGN
$61.5B
| $14.4M | 0.2% |
23,100
+4,000
| +21% | +$2.49M |
|
94
Zai Lab
ZLAB
$3.68B
| $14.4M | 0.2% |
175,100
+21,100
| +14% | +$1.73M |
|
95
Omnicell
OMCL
$1.5B
| $14.3M | 0.2% |
202,131
+5,995
| +3% | +$423K |
|
|
NVRO
96
DELISTED
NEVRO CORP.
NVRO
| $13.4M | 0.19% |
111,762
+31,856
| +40% | +$3.81M |
|
97
Quanterix
QTRX
$211M
| $13.1M | 0.19% |
477,515
+31,842
| +7% | +$872K |
|
|
AMED
98
DELISTED
Amedisys
AMED
| $12.1M | 0.17% |
61,143
| – | – |
|
|
TRHC
99
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $11.9M | 0.17% |
216,581
+7,772
| +4% | +$425K |
|
100
10x Genomics
TXG
$1.74B
| $11M | 0.16% |
123,077
+29,230
| +31% | +$2.61M |
|